Cancer Communications
indexed by SCI
BMC

[ Special series on Colorectal Cancer ]
doi: 10.1186/s40880-015-0067-x
Expert consensus on maintenance treatment for metastatic colorectal cancer in China
Rui-Hua Xu, Lin Shen, Jin Li, Jian-Ming Xu, Feng Bi, Yi Ba, Li Bai, Yong-Qian Shu, Tian-Shu Liu, Yu-Hong Li, Chun-Mei Bai, Xiang-Lin Yuan, Jun Zhang, Gong Chen, Ai-Ping Zhou, Ying Yuan, Xi-Jing Wang, Xiao-Ping Qian and Yan-Hong Deng
Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine; Department of Medical Oncology, Sun Yat-sen University Cancer Center
[Abstract] The impact of maintenance therapy on progression-free survival and overall survival as well as quality of life of Chinese patients with metastatic colorectal cancer has long been under discussion. Recently, some phase III clinical trials have revealed that maintenance therapy can significantly prolong the progression-free survival while maintain an acceptable safety profile. Based on this evidence and common treatment practice in China, we now generated one Expert Consensus on Maintenance Treatment for Metastatic Colorectal Cancer in China to further specify the necessity of maintenance therapy, suitable candidates for such treatment, and appropriate regimens.
Chinese Journal of Cancer 2016, Volume: 35, Issue 1
[ PDF Full-text ]
[ Html full-text / Citation export] (BioMed Central)

[Google Scholar]


[ More articles of the special series on Colorectal Cancer ]


Cite this article

Rui-Hua Xu, Lin Shen, Jin Li, Jian-Ming Xu, Feng Bi, Yi Ba, Li Bai, Yong-Qian Shu, Tian-Shu Liu, Yu-Hong Li, Chun-Mei Bai, Xiang-Lin Yuan, Jun Zhang, Gong Chen, Ai-Ping Zhou, Ying Yuan, Xi-Jing Wang, Xiao-Ping Qian and Yan-Hong Deng. Expert consensus on maintenance treatment for metastatic colorectal cancer in China. Chin J Cancer. 2016, 35:13. doi:10.1186/s40880-015-0067-x


Export citations

EndNote


SHARE THIS ARTICLE


Your Comments

  

 


Comments:


CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East, Guangzhou 510060, P. R. China